ZTS · News · 20261112N
Product Launch and Transition
Zoetis Inc. · 2026-11-12 · Importance 34 · Surprise 42
The USDA licensed Zoetis’ Cytopoint Plus for treating allergic dermatitis in dogs. The next-generation monoclonal antibody provides 75 days of itch relief in one veterinarian-administered injection, described as the longest treatment interval among USDA-licensed monoclonal antibodies for the condition. The product adds a longer-duration option to Zoetis’ canine dermatology franchise.
Key facts
- The Cytopoint Plus license adds a longer-duration option to Zoetis' canine dermatology franchise and expands its treatments for chronic itch in dogs. source
- Zoetis described Cytopoint Plus as a veterinarian-administered injection providing 75 days of relief from allergic itch, the longest treatment interval among USDA-licensed monoclonal antibodies for the condition. source